Error: Could not add to watchlist. X
+ Watchlist

Galapagos NV

GLPG:BB
EN Brussels
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-1.45
Market Cap (EUR)
-
Shares Outstanding (m)
46.256
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.23%
% Price Change
+1.47%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action, with a pipeline comprising Phase 3, 2, 1, pre-clinical and discovery studies in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.
Address
Generaal De Wittelaan L11 A3
Industriepark Mechelen Noord
Mechelen, 2800
Belgium
Phone
32-15-34-2900
Show More